Consensus Conference on Patient Specific Therapy

November 2, 2003
Hyatt Regency
Bethesda, MD

Robert K. Oldham, MD
Cancer Therapeutics, Thomasville, GA
Larry Kwak, MD, PhD
National Cancer Institute, Frederick, MD
Kenneth A. Foon, MD
University of Pittsburgh Cancer Institute, Pittsburgh, PA

This half day Conference that immediately follows the Annual Meeting is intended as a forum for discussing issues related to personalized medicine. The program will include presentations by the NCI, FDA, and industry leaders and conclude with a panel discussion. The goal of the conference is to develop a better understanding of the problems and opportunities in developing Patient Specific Therapy in the context of current FDA regulations and drug development costs.

11:00am Pick Up Box Lunches
11:00-11:20am Anti-Idiotypic Antibodies – Kenneth A. Foon, MD
11:20-11:40am Idiotype Vaccines – Larry Kwak, MD, PhD
11:40am-12:00pm T-cell Therapy – Mark Dudley, PhD
12:00-12:20pm Dendritic Cell Therapy – Theresa Whiteside, PhD
12:20-12:40pm Gene Modified Tumor Vaccines – Kristen Hege, MD
12:40-1:00pm Autologous Tumor Vaccine Heat Shock Proteins – John Lewis, MD, PhD
1:00-1:20pm Position talk from NCI – Howard Streicher, MD
1:20-1:40pm Position talk from FDA – Raj Puri, MD, PhD
1:40-2:00pm Position talk from Industry – Robert Oldham, MD
2:00-2:30pm Break
2:30-4:30pm Panel Discussion

Co-Chairs/Speakers:

Laura G. Franco, MD
University of Pittsburgh Cancer Institute
Pittsburgh, PA

Bryan Gray, MD, PhD
Nat’l Cancer Institute
Frederick, MD

David J. Hamilton, MD
Univ. of Pittsburgh Cancer Institute
Thomasville, GA

Panelists:

Bobby Radel
CancerDrugsNow.Org
New York, NY

William Redd, PhD
Toucan Capital Corp.
Bethesda, MD

Speakers:

Mark Cochran, PhD
National Institutes of Health
Bethesda, MD

Elaine McLaughlin, MD
Cell Genesys
South San Francisco, CA

Thomas Emmert, MD, PhD
Antigenics, Inc.
New York, NY

Patrick Chestnut, PhD
Food and Drug Administration
Bethesda, MD

Eric Wong, MD
Cancer Therapy Evaluation Program
National Cancer Institute
Bethesda, MD

Ann Clarke, PhD
University of Pittsburgh Cancer Institute
Pittsburgh, PA

Registration Fees
$100 all classes*

*Discounts available